OR4F13P: Key Component of The Olfactory System (G390651)
OR4F13P: Key Component of The Olfactory System
OR4F13P, also known as Olfactory receptor family 4 subfamily F member 13 pseudogene, is a gene that encodes a protein known as OR4F13P, which is a key component of the olfactory system. The olfactory system is responsible for the sense of smell and is composed of various proteins that transmit information about the sensory environment to the brain.
OR4F13P is one of the proteins that make up the Olfactory receptor family 4, which is a group of proteins that are involved in the sense of smell. This family of proteins is known for their ability to detect and respond to different types of sensory stimuli, including the axoplasm transports substances and odors.
OR4F13P is a 21-kDa protein that is expressed in the central nervous system (CNS) and is involved in the sense of smell. It is a single-transmembrane protein that is composed of a cytoplasmic tail and a transmembrane region. The cytoplasmic tail of OR4F13P is involved in the formation of the protein-protein interaction and in the regulation of the intracellular signaling pathway.
OR4F13P functions as a receptor for smell, specifically for the smell of cinnamaldehyde. Cinnamaldehyde is a common ingredient in many foods, such as cinnamon, cloves, and nutmeg, and is known for its strong and fragrant smell. When cinnamaldehyde is present in the environment , it is detected by OR4F13P and triggers a signaling cascade that results in the release of signals in the CNS.
OR4F13P is also involved in the regulation of the olfactory system in the sense of taste. Taste is a type of sensory experience that is different from smell, but is still important for the sense of taste. OR4F13P is involved in the sense of taste because it is a receptor for sweet and sour tastes, as well as for bitterness.
OR4F13P is a potential drug target because of its involvement in the sense of smell and taste. Many diseases, including cancer, neurodegenerative diseases, and psychiatric disorders, are associated with changes in the sense of smell and taste. Therefore, targeting OR4F13P with drugs that can modulate its function may be a promising approach to treating these diseases.
In addition to its involvement in the sense of smell and taste, OR4F13P is also involved in the regulation of the olfactory system in the sense of touch. Tactile sensitivity is an important aspect of the sense of touch and is mediated by the Olfactory receptor family 5 . OR4F13P is known to interact with this receptor and may be involved in the regulation of tactile sensitivity.
OR4F13P is also a good candidate as a biomarker for certain diseases. For example, it may be used as a biomarker for neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. These diseases are characterized by the progressive loss of nerve cells and can result in a range of symptoms, including cognitive decline, motor dysfunction, and behavioral changes.
In conclusion, OR4F13P is a protein that is involved in the sense of smell and taste and is a potential drug target. Its involvement in the regulation of the olfactory system makes it an attractive target for the development of therapies for diseases associated with these senses. Furthermore, OR4F13P is also involved in the regulation of the sense of touch and may be used as a biomarker for certain diseases. Further research is needed to fully understand the role of OR4F13P in the sense of smell and taste and its potential as a drug target and biomarker.
Protein Name: Olfactory Receptor Family 4 Subfamily F Member 13 Pseudogene
The "OR4F13P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR4F13P comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1
